Sigma Planning Corp’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History

Sigma Planning Corp’s Portfolio DRNA Stock Details DRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-14,016	Closed	-$283K	–	1504
2021 Q3	$283K	Sell	14,016 -1,784	-11%	-$49.3K	0.01%	1088
2021 Q2	$590K	Buy	15,800 +6,940	+78%	+$213K	0.02%	763
2021 Q1	$227K	Buy	+8,860	New	+$226K	0.01%	1140

Other funds holding DRNA

CAM

Close Asset Management London, United Kingdom $3.69B AUM 21.62% 1-Year Est. Return

Sigma Planning Corp's DRNA Position: Q4 2021 in Review

Sigma Planning Corp sold out of Dicerna Pharmaceuticals, Inc. (DRNA) in Q4 2021, closing a stake of 14,016 shares — an estimated $283K sold.

Sigma Planning Corp first reported a position in DRNA in Q1 2021 and held it in 3 quarters. The position peaked at $590K in Q2 2021. 1 fund tracked by Wall St. Rank holds DRNA as of Q4 2021.

Sigma Planning Corp reported no remaining Dicerna Pharmaceuticals, Inc. position as of Q4 2021 after selling out during the quarter.
Sigma Planning Corp sold 14,016 Dicerna Pharmaceuticals, Inc. shares in Q4 2021, an estimated $283K.
Sigma Planning Corp first reported a position in Dicerna Pharmaceuticals, Inc. in Q1 2021 and held it in 3 quarters.
Sigma Planning Corp's Dicerna Pharmaceuticals, Inc. position peaked at $590K in Q2 2021.
1 fund tracked by Wall St. Rank held Dicerna Pharmaceuticals, Inc. as of Q4 2021.

Based on Sigma Planning Corp's 13F filing for Q4 2021, filed 2 Feb 2022.